{"slideshow_credits": null, "snippet": "Results of a clinical trial, disclosed at a medical meeting in Chicago, showed that patients given trametinib lived longer than those receiving chemotherapy for advanced stages of the cancer.", "abstract": "GlaxoSmithKline's new drug trametinib prolongs the lives of patients with advanced melanoma in a clinical trial, adding to two drugs that have already received regulatory approval.", "section_name": "Health", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/06/04/health/glaxosmithkline-melanoma-drug-prolongs-patients-lives.html", "lead_paragraph": "Results of a clinical trial, disclosed at a medical meeting in Chicago, showed that patients given trametinib lived longer than those receiving chemotherapy for advanced stages of the cancer.", "headline": {"seo": "GlaxoSmithKline Melanoma Drug Prolongs Patients&#8217; Lives", "main": "A Drug for Advanced Melanoma Is Found to Prolong Patients&#8217; Lives", "print_headline": "A Drug for Advanced Melanoma Is Found to Prolong Patients\u2019 Lives"}, "_id": "53f770fb38f0d835538dbd89", "word_count": "716", "multimedia": [], "pub_date": "2012-06-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Melanomas", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Skin Cancer", "name": "subject", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}